Needham analyst Serge Belanger downgrades Clarus Therapeutics Hldgs (NASDAQ:CRXT) from Buy to Hold.
Where Planet Labs Stands With Analysts
Analysts have provided the following ratings for Planet Labs (NYSE:PL) within the last quarter: Bullish Somewhat Bullish Indifferent…